Canadian brain bank network to advance research on Alzheimer鈥檚 disease
More than 400,000 Canadians aged 65 and over live with diagnosed dementia, including Alzheimer鈥檚 disease, which accounts for approximately 70 percent of cases. The cause of this degenerative brain disease is largely unknown and no effective treatment exists. The disease has a devastating effect on individuals and their families.
To advance our understanding of dementia and contribute to the search for new treatments, Mr. Anthony Housefather, Member of Parliament for Mont Royal, today announced, on behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, an investment of $2.5 million from the Government of Canada for dementia research.
鈥淐anadian researchers are making important contributions to understanding dementia and improving the prevention, treatment and care of people living with dementia,鈥� noted the Honourable Ginette Petitpas Taylor. 鈥淭his investment will support Canadian researchers who will collaborate with international colleagues as part of the global response to dementia.鈥�
The funding includes $1 million to establish a Canadian brain bank network that will be linked to the international Alzheimer 鈥檚 disease Neuroimaging Initiative (ADNI). The Canadian ADNI BraIn bank Network, or CABIN, will provide the personnel and physical infrastructure needed to contribute to the ADNI program and more broadly support brain donation and tissue banking for dementia research programs in Canada. The project will be led by Dr. Ian Mackenzie and Dr. Robin Hsuing at the University of British Colombia and Dr. Howard Chertkow at the Jewish General Hospital and 不良研究所.
Additional funding for dementia-related projects
In addition to the CABIN funding, research led by Dr. Nahum Sonenberg, James 不良研究所 Professor and the Gilman Cheney Chair in Biochemistry in 不良研究所鈥檚 Department of Biochemistry, is one of three international projects sharing $1.5 million in funding through the The European Union created the Joint Programme on Neurodegenerative Disease Research (JPND). The JPND was created to better coordinate European research efforts on dementia and other neurodegenerative diseases such as Parkinson鈥檚 disease. Canada, Australia, and Switzerland are non-EU countries participating in the programme, which facilitates collaborative research projects involving scientists in member countries. The three projects were selected following a call for proposals from the Canadian Institutes of Health Research (CIHR).
Titled 鈥淎ltered mRNA translation as a pathogenic mechanism across neurodegenerative diseases,鈥� Dr. Sonenberg鈥檚 initiative will aim to better understand the mechanisms responsible for altering the manufacture of proteins in Alzheimer鈥檚 disease and other neurodegenerative diseases and to identify potential targets for drug development. The research will be done in collaboration with colleagues in Germany, Israel, the United Kingdom, France and the Netherlands.
鈥湶涣佳芯克� and the Jewish General Hospital are world leaders in brain research and the treatment of dementia and other neurodegenerative diseases,鈥� said Anthony Housefather, M.P., Member of Parliament for Mont Royal. 鈥淚 congratulate the researchers receiving funding in Montreal and across the country and wish them every success in their work.鈥�
The Government of Canada is currently developing a national dementia strategy that will be evidence-based and build on the innovative work already underway across the country.
鈥淐IHR鈥檚 Dementia Research Strategy is guiding research investments in a way that maximizes Canada鈥檚 scientific strengths and accelerates dementia research in this country and internationally. These research projects will move us closer to finding an effective treatment for this devastating disease,鈥� said Dr. Yves Joanette, Scientific Director at the CIHR Institute of Aging.
(With files from the Canadian Institutes of Health Research)
related to Dr. Sonenberg鈥檚 research
Controlling Protein Synthesis - With Nahum Sonenberg
Professor Nahum Sonenberg describes his discoveries that elucidated the protein synthesis molecular machinery of our cells that regulates the types and amounts of proteins produced. We also learn how poliovirus hijacks the cell鈥檚 production system to produce viral rather than cellular proteins.
On Cancer, Autism and Memory
With Nahum Sonenberg
Professor Nahum Sonenberg describes the selection machinery used in cells to make proteins. We learn how errors in this mechanism can lead to cancer, autism spectrum disorders and changes to the memory capacity of the brain.
Associated Links
